Xiao C - Search Results

1

ROBO1 deficiency impairs HSPC homeostasis and erythropoiesis via CDC42 and predicts poor prognosis in MDS.

Jin JC, Chen BY, Deng CH, Chen JN, Xu F, Tao Y, Hu CL, Xu CH, Chang BH, Wang Y, Fei MY, Liu P, Yu PC, Li ZJ, Li XY, Chen SB, Jiang YL, Chen XC, Zong LJ, Zhang JY, Ren YY, Xu FH, Liu Q, Huang XH, Guo J, He Q, Song LX, Zhou LY, Su JY, Xiao C, Zhang YM, Yan M, Zhang Z, Wu D, Chang CK, Li X, Wang L, Wu LY. Jin JC, et al. Among authors: xiao c. Sci Adv. 2023 Dec;9(48):eadi7375. doi: 10.1126/sciadv.adi7375. Epub 2023 Nov 29. Sci Adv. 2023. PMID: 38019913 Free article.

2

[Yield of CD34(+) cells in graft can be increased significantly by G-CSF used at appropriate time after chemotherapy for AutoPBSCT].

Xu L, Chang CK, Gan WJ, Su JY, Zhang X, Wu LY, Song LX, He Q, Zhou LY, Xiao C, Liu H, Li X. Xu L, et al. Among authors: xiao c. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Jun;19(3):759-63. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011. PMID: 21729566 Clinical Trial. Chinese.

3

[The affection of bisphosphonates combined with chemotherapy on bone metabolism index in multiple myeloma].

Zhang X, Chang CK, Wu LY, Zhang Z, Zhou LY, Xiao C, Li X. Zhang X, et al. Among authors: xiao c. Zhonghua Xue Ye Xue Za Zhi. 2011 Oct;32(10):660-3. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 22339822 Clinical Trial. Chinese.

4

[Research advances of hepcidin expression and its regulation mechanism].

Chang CK, Zhang X, Xiao C, Gu SC, Li X. Chang CK, et al. Among authors: xiao c. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Aug;20(4):1030-3. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012. PMID: 22931678 Review. Chinese.

5

[Influence of bisphosphonate combined with chemotherapy on bone mineral density of patients with multiple myeloma].

Zhang X, Chang CK, Zhang Z, Zhao YS, Xiao C, Li X. Zhang X, et al. Among authors: xiao c. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Oct;20(5):1135-8. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012. PMID: 23114134 Clinical Trial. Chinese.

6

High expression of APAF-1 elevates erythroid apoptosis in iron overload myelodysplastic syndrome.

Gu S, Zhao Y, Guo J, Xu F, Fei C, Zhang X, Xiao C, Chang C, Li X. Gu S, et al. Among authors: xiao c. Tumour Biol. 2014 Mar;35(3):2211-8. doi: 10.1007/s13277-013-1294-x. Epub 2013 Oct 19. Tumour Biol. 2014. PMID: 24142530 Free PMC article.

7

[Function of peripheral blood Th17 cells in patients with multiple myeloma].

Zhang Y, Song LX, Zhang X, Xiao C, Chang CK. Zhang Y, et al. Among authors: xiao c. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1187-9. doi: 10.7534/j.issn.1009-2137.2013.05.020. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 24156431 Chinese.

8

[Clinical analysis of neutrophil suppression caused by decitabine for the treatment of myelodysplastic syndromes].

Wu D, Li X, Chang C, Wu L, Su J, Zhang X, Zhou L, Song L, He Q, Xiao C, Zhang Z, Guo C. Wu D, et al. Among authors: xiao c. Zhonghua Xue Ye Xue Za Zhi. 2014 Feb;35(2):173-5. doi: 10.3760/cma.j.issn.0253-2727.2014.02.026. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24606665 Chinese. No abstract available.

9

[Large granular lymphocyte leukemia].

Xiao C, Zhang X, Chang CK. Xiao C, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Jun;22(3):829-35. doi: 10.7534/j.issn.1009-2137.2014.03.048. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014. PMID: 24989304 Review. Chinese.

10

[Iron chelation therapy and its influence on the alleviation of EPO resistance in MDS patients].

Zhang Y, Xiao C, Gu SC, Chang CK. Zhang Y, et al. Among authors: xiao c. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Aug;22(4):1027-32. doi: 10.7534/j.issn.1009-2137.2014.04.026. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014. PMID: 25130822 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,727 results

Search Page

Filters